SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-025464
Filing Date
2024-03-05
Accepted
2024-03-05 10:01:45
Documents
123
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mcrb-20231231.htm   iXBRL 10-K 3657203
2 EX-4.2 mcrb-ex4_2.htm EX-4.2 27533
3 EX-10.6 mcrb-ex10_6.htm EX-10.6 834971
4 EX-10.26 mcrb-ex10_26.htm EX-10.26 338653
5 EX-23.1 mcrb-ex23_1.htm EX-23.1 2579
6 EX-31.1 mcrb-ex31_1.htm EX-31.1 11343
7 EX-31.2 mcrb-ex31_2.htm EX-31.2 11636
8 EX-32.1 mcrb-ex32_1.htm EX-32.1 7504
9 EX-32.2 mcrb-ex32_2.htm EX-32.2 7052
10 EX-97.1 mcrb-ex97_1.htm EX-97.1 31398
11 GRAPHIC img233233405_0.jpg GRAPHIC 10164
12 GRAPHIC img233233405_1.jpg GRAPHIC 10164
13 GRAPHIC img233233405_2.jpg GRAPHIC 10164
14 GRAPHIC img233233405_3.jpg GRAPHIC 10164
15 GRAPHIC img233233405_4.jpg GRAPHIC 10164
  Complete submission text file 0000950170-24-025464.txt   15756005

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mcrb-20231231.xsd EX-101.SCH 2056383
125 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20231231_htm.xml XML 2384765
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37465 | Film No.: 24718591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)